Economic evaluations of technologies used in health organizations: Integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v14i2.48207

Keywords:

Health Care Economics and Organizations; Biomedical Technology; Costs and Cost Analysis.

Abstract

Objective: To map the main economic evaluations of technology used in health organizations. Method: This is an integrative review, with 6 stages (Souza et al, 2010) with research in the databases, with articles published between 2018 and November 19, 2022. Studies with health economic evaluations (HEE) with economic indicators of results and costs of interventions from the perspective of health organizations. Studies with no economic data, without comparative economic analyses, literature reviews, articles with unavailable texts, opinions and decisions of government bodies were excluded. Results: At the end of the selection, 13 studies were considered in this review, a small amount of HEE and an incidence in economically developed countries can be seen. Discussion: The articles present relevant data, however it is necessary to evolve with the use of the concepts of the criteria of the types of HEE, an effective methodology needs to observe the perspective of the study, its time horizon and the costs and results related to the decision makers from that perspective. Final considerations: It is essential to include in the next HEE indicators valued with human resources, indirect costs, length of stay and better mapping and detailing of costs from the perspective of health organizations.

References

Aitken, E., Kearns, R., Gaianu, L., Jackson, A., Steven, M., Kinsella, J., Clancy, M., & Macfarlane A. (2020). Long-term functional patency and cost-effectiveness of arteriovenous fistula creation under regional anesthesia: A randomized controlled trial. Journal of the American Society of Nephrology, 31(8), 1871–1882. https://doi.org/10.1681/asn.2019111209

Alves, D. F. A., Carnut, L., & Mendes, Á. (2019). Dimensionamento da “economia política” na “economia da saúde”: para refletir sobre o conceito de sustentabilidade. Saúde em Debate, 43(esp 5), 145–160. https://doi.org/10.1590/0103-11042019s513

Armstrong R., Hall B. J., Doyle J., Waters E. Cochrane Update. 'Scoping the scope' of a cochrane review. Journal of Public Health, 33(1):147–50. https://doi.org/10.1093/pubmed/fdr015

Benger, J. R., Kirby, K., Black, S., Brett, S. J., Clout, M., Lazaroo, M. J., Nolan, J. P., Reeves, B. C., Robinson, M., Scott, L. J., Smartt, H., South, A., Stokes, E. A., Taylor, J., Thomas, M., Voss, S., Wordsworth, S., & Rogers, C. A. (2022). Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: The AIRWAYS-2 cluster RCT. Health Technology Assessment, 26(21), 1-158. https://doi.org/10.3310/vhoh9034

Boden, I., Robertson, I. K., Neil, A., Reeve, J., Palmer, A. J., Skinner, E. H., Browning, L., Anderson, L., Hill, C., Story, D., & Denehy, L. (2020). Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: A health economic analysis of a multicentre randomised trial. Journal of Physiotherapy, 66(3), 180–187. https://doi.org/10.1016/j.jphys.2020.06.005

Dasgupta, R., Cameron, S., Aucott, L., MacLennan, G., Kilonzo, M. M., Lam, T. B., Thomas, R., Norrie, J., McDonald, A., Anson, K., N'Dow, J., Burgess, N., Clark, C. T., Keeley, F. X., MacLennan, S. J., Starr, K., & McClinton, S. (2022). Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT. Health Technology Assessment (Winchester, England), 26(19), 1–70. https://doi.org/10.3310/wuzw9042

Dermindo, M. P., Guerra, L. M., & Gondinho, B. V. C. (2020). O conceito eficiência na gestão da saúde pública brasileira: Uma revisão integrativa da literatura. JMPHC | Journal of Management & Primary Health Care, 12, 1–17. https://doi.org/10.14295/jmphc.v12.972

Drugdová, I., Rogalewicz, V., Šrámek, M., Kopalová, V., Krahula, O., Gavurová, B. & Barták, M. (2020). Health-related quality of life measures for a cost-effectiveness analysis of ischemic stroke therapie. Kontakt - Journal of Nursing and Social Sciences related to Health and Illness, 22(2), 128–136. http://doi.org/10.32725/kont.2020.019

Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes (4nd ed.). Oxford University Press.

Federação Brasileira de Hospitais & Confederação Nacional de Saúde. (2022). Cenário dos hospitais no Brasil: 2021-2022. Federação Brasileira de Hospitais, Confederação Nacional de Saúde. http://cnsaude.org.br/wp-content/uploads/2021/05/CNSAUDE-FBH-CENARIOS-2022.pdf

Frear, C. C., Griffin, B. R., Cuttle, L., Kimble, R. M., & McPhail, S. M. (2021). Cost-effectiveness of adjunctive negative pressure wound therapy in paediatric burn care: evidence from the SONATA in C randomised controlled trial. Scientific Reports, 11(1), 16650. https://doi.org/10.1038/s41598-021-95893-9

Gould, D. W., Doidge, J., Sadique, M. Z., Borthwick, M., Hatch, R., Caskey, F. J., Forni, L., Lawrence, R. F., MacEwen, C., Ostermann, M., Mouncey, P. R., Harrison, D. A., Rowan, K. M., Young, J. D., & Watkinson, P. J. (2022). Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study. Health Technology Assessment, 26(13), 1–58. https://doi.org/10.3310/zxhi9396

Kinoshita, T., Moriwaki, K., Hanaki, N., Kitamura, T., Yamakawa, K., Fukuda, T., Hunink, M. G. M., & Fujimi, S. (2021). Cost-effectiveness of a hybrid emergency room system for severe trauma: a health technology assessment from the perspective of the third-party payer in Japan. World Journal of Emergency Surgery, 16(1), 2. https://doi.org/10.1186/s13017-020-00344-x

Kumar, P., Sundermann, A. J., Martin, E. M., Snyder, G. M., Marsh, J. W., Harrison, L. H., & Roberts, M. S. (2021). Method for Economic Evaluation of Bacterial Whole Genome Sequencing Surveillance Compared to Standard of Care in Detecting Hospital Outbreaks. Clinical Infectious Diseases, 73(1), p. e9–e18. https://doi.org/10.1093/cid/ciaa512

Leira, R. R., & Costa, R. (2018). Análise de custo-efetividade da rivaroxabana versus enoxaparina no tratamento da trombose venosa profunda em pacientes com câncer ginecológico. Jornal Brasileiro de Economia da Saúde, 10(1), 2–8. https://doi.org/10.21115/JBES.v10.n1.p2-8

Mauskopf, J. A., Sullivan, S. D., Annemans, L., Caro, J. J., Mullins, C. D., Nuijten, M., Orlewska, E., Watkins, J., & Trueman, P. (2007). Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 10(5), 336-347. https://doi.org/10.1111/j.1524-4733.2007.00187.x

Meirelles, I. O., Couto, D. H. N., Costa, R. S. D. (2019). Cost-effectiveness between pazopanib and sunitinib for metastatic renal cancer from the perspective of the Brazilian Unified National Health System. Cadernos de Saude Publica, 35(8), e00108218. https://doi.org/10.1590/0102-311x00108218

Ministério da Saúde. (2014). Diretrizes metodológicas: diretriz de avaliação econômica (2a ed.). Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia. https://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_diretriz_avaliacao_economica.pdf

Rathore, C. et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ’ s public news and information. n. January, 2020.

Romanò, C. L., Trentinaglia, M. T., De Vecchi, E., Logoluso, N., George, D. A., Morelli, I., & Drago, L. (2018). Cost-benefit analysis of antibiofilm microbiological techniques for peri-prosthetic joint infection diagnosis. BMC Infectious Diseases, 18(1), 154. https://doi.org/10.1186/s12879-018-3050-8

Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: o que é? Como fazer? Einstein (Sao Paulo), 8(1), 102–106. https://doi.org/10.1590/S1679-45082010RW1134

Thacharodi, A., Singh, P., Meenatchi, R., Tawfeeq Ahmed, Z. H., Kumar, R. R. S., V, N., Kavish, S., Maqbool, M., & Hassan, S. (2024). Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future - A comprehensive review. Health Care Science, 3(5), 329-349. https://doi.org/10.1002/hcs2.115

Published

16/02/2025

How to Cite

CAVALCANTI FILHO, F. L.; LINARD, C. F. B. M. Economic evaluations of technologies used in health organizations: Integrative review. Research, Society and Development, [S. l.], v. 14, n. 2, p. e5514248207, 2025. DOI: 10.33448/rsd-v14i2.48207. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/48207. Acesso em: 30 mar. 2025.

Issue

Section

Review Article